C O R P O R A T E G O V E R N A N C E S T A T E M E N T ASX : CUV | Nasdaq : CUVL | Börse Frankfurt: UR9 ASX Announcement PAGE 1 OF 11 CLINUVEL PHARMACEUTICALS LTD ( ‘COMPANY’) This statement reports on the main corporate governance practices of the Company as...
Corporate Governance Statement
Filed with ASX ·
Watch Clinuvel Pharmaceuticals' latest callClinuvel Pharmaceuticals (ASX:CUV) Q4 2026 Earnings Call · Replay · Aug 27Read the transcript of Clinuvel Pharmaceuticals (ASX:CUV) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Clinuvel Pharmaceuticals Limited on 6ix
In the deck
Earlier from Clinuvel Pharmaceuticals
- Dividend/Distribution - CUV
- CLINUVEL Annual Results - Investor Webinar
- Becoming a substantial holder
- CLINUVEL's injectable peptide platform
- Commercial update on vitiligo
Later from Clinuvel Pharmaceuticals
- Appendix 4G
- Investor Presentation
- A decade of profitability provides U.S. expansion foundation
- Appendix 4E and Annual Report to Shareholders 2026
- CLINUVEL considers Nasdaq listing, ASX delisting
Follow Clinuvel Pharmaceuticals into a list and get an email when it puts out news.
Follow Clinuvel Pharmaceuticals